Jane Anne Shaw, DO | |
240 Hospital Dr Ne, Bolivia, NC 28422-8346 | |
(910) 721-2070 | |
(910) 721-2074 |
Full Name | Jane Anne Shaw |
---|---|
Gender | Female |
Speciality | Hospitalist |
Location | 240 Hospital Dr Ne, Bolivia, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427452812 | NPI | - | NPPES |
Entity Name | Western Virginia Regional Emergency Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386183028 PECOS PAC ID: 4183991227 Enrollment ID: O20170522001368 |
News Archive
The COVID-19 pandemic's heavy toll on older Americans highlights the need to strengthen the nation's safety net for people in need of long-term services and supports, an Oregon Health & Science University researcher and co-authors argue in a new report published by Milbank Quarterly.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that several ImmunoGen poster presentations will be made at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA, on November 15-19, 2009.
The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Kobe University and Alfresa Pharma Corporation develop a novel medical device with non-woven fabric style made of bioabsorbable material.
Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2010.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jane Anne Shaw, DO Po Box 60447, Charlotte, NC 28260-0447 Ph: (910) 721-2070 | Jane Anne Shaw, DO 240 Hospital Dr Ne, Bolivia, NC 28422-8346 Ph: (910) 721-2070 |
News Archive
The COVID-19 pandemic's heavy toll on older Americans highlights the need to strengthen the nation's safety net for people in need of long-term services and supports, an Oregon Health & Science University researcher and co-authors argue in a new report published by Milbank Quarterly.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that several ImmunoGen poster presentations will be made at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA, on November 15-19, 2009.
The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Kobe University and Alfresa Pharma Corporation develop a novel medical device with non-woven fabric style made of bioabsorbable material.
Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2010.
› Verified 3 days ago